Aggressive multimodal therapy (surgery, mitotane, RFA for oligometastatic disease) achieved long-term remission in this high-risk ACC (Ki-67 14%), suggesting potential benefit of comprehensive treatment in young patients. Here, MKI67 is linked to adrenal cortex carcinoma.